N-(4-((Octylamino)methyl)benzyl)-4-methoxythieno[2,3-d]-pyrimidine-5-carboxamide

ID: ALA4578960

Chembl Id: CHEMBL4578960

PubChem CID: 155565409

Max Phase: Preclinical

Molecular Formula: C24H32N4O2S

Molecular Weight: 440.61

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCNCc1ccc(CNC(=O)c2csc3ncnc(OC)c23)cc1

Standard InChI:  InChI=1S/C24H32N4O2S/c1-3-4-5-6-7-8-13-25-14-18-9-11-19(12-10-18)15-26-22(29)20-16-31-24-21(20)23(30-2)27-17-28-24/h9-12,16-17,25H,3-8,13-15H2,1-2H3,(H,26,29)

Standard InChI Key:  DZNFWLNRLLFPIR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4578960

    ---

Associated Targets(non-human)

trmD tRNA (guanine-N(1)-)-methyltransferase (63 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 440.61Molecular Weight (Monoisotopic): 440.2246AlogP: 5.08#Rotatable Bonds: 13
Polar Surface Area: 76.14Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.60CX LogP: 5.19CX LogD: 3.02
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.36Np Likeness Score: -1.23

References

1. Zhong W, Pasunooti KK, Balamkundu S, Wong YH, Nah Q, Gadi V, Gnanakalai S, Chionh YH, McBee ME, Gopal P, Lim SH, Olivier N, Buurman ET, Dick T, Liu CF, Lescar J, Dedon PC..  (2019)  Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-N1)-Methyltransferase (TrmD) by Restructuring the Active Site with a Tyrosine-Flipping Mechanism.,  62  (17): [PMID:31442049] [10.1021/acs.jmedchem.9b00582]

Source